Active substances
Articaine + Epinephrine
- SFDA 4
- US FDA 6
- Health Canada 14
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Orabloc | 40,18.2 mg/ml,mg/ml | Solution for injection in cartridge · Dental use | 50 Cartridge | SAR 99.40 | Generic · Prescription | PIERREL PHARMA S.R.L. | Valid |
| Orabloc | 40,9.1 mg/ml,mg/ml | Solution for injection in cartridge · Dental use | 50 Cartridge | SAR 99.40 | Generic · Prescription | PIERREL PHARMA S.R.L. | Valid |
| SEPTANEST N 1-200000 DENTAL CARTRIDGE | 0.005,40 mg,mg | Solution for injection · Dental use | 50 Cartridge | SAR 104.35 | NCE · Prescription | SEPTODENT | Valid |
| SEPTANEST SP 1-100000 DENTAL CARTRIDGE | 0.01,40 mg,mg | Solution for injection · Dental use | 50 Cartridge | SAR 104.35 | NCE · Prescription | SEPTODENT | Valid |
Indications — CHI Daman Drug Formulary
ANESTHESIA
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| SEPTOCAINE | 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG BASE/ML); 4%; EQ 0.0085MG BASE/1.7ML (4%; EQ 0.005MG BASE/ML) | injectable · injection | DEPROCO | Prescription | 3 Apr 2000 |
| SEPTOCAINE | 4%;EQ 0.0085MG BASE/1.7ML (4%;EQ 0.005MG BASE/ML) | injectable · injection | DEPROCO | Prescription | 30 Mar 2006 |
| ORABLOC | 4%;EQ 0.009MG BASE/1.8ML (EQ 0.005MG BASE/ML); 4%;EQ 0.018MG BASE/1.8ML (EQ 0.01MG BASE/ML) | injectable · injection | PIERREL | Prescription | 26 Feb 2010 |
| ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG BASE/ML) | injectable · injection | HOSPIRA | Discontinued | 18 Jun 2010 |
| ULTACAN FORTE | 4%;EQ 0.017MG BASE/1.7ML (4%; EQ 0.01MG BASE/ML) | injectable · injection | HANSAMED INC | Discontinued | 11 Jul 2017 |
| ULTACAN | 4%;EQ 0.0085MG BASE/1.7ML (4%; EQ 0.005MG BASE/ML) | injectable · injection | HANSAMED INC | Discontinued | 11 Jul 2017 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| 4% ASTRACAINE DENTAL WITH EPINEPHRINE 1:200,000 (0.005MG/ML) | 02248489 | 0.005 MG / ML; 40 MG / ML | SOLUTION · BLOCK/INFILTRATION | DENTSPLY CANADA LIMITED |
| 4% ASTRACAINE DENTAL WITH EPINEPHRINE FORTE 1:100,000 (0.01MG/ML) | 02248488 | 40 MG / ML; 0.01 MG / ML | SOLUTION · BLOCK/INFILTRATION | DENTSPLY CANADA LIMITED |
| ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION | 02339536 | 40 MG / ML; 0.009 MG / ML | SOLUTION · BLOCK/INFILTRATION | PIERREL S.P.A. |
| ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION | 02339544 | 0.018 MG / ML; 40 MG / ML | SOLUTION · BLOCK/INFILTRATION | PIERREL S.P.A. |
| ARTICAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION - N | 02561980 | 40 MG / ML; 0.005 MG / ML | SOLUTION · BLOCK/INFILTRATION | SEPTODONT |
| ARTICAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION - SP | 02561999 | 40 MG / ML; 0.01 MG / ML | SOLUTION · BLOCK/INFILTRATION | SEPTODONT |
| ORABLOC 1:100,000 | 02361914 | 40 MG / ML; 0.018 MG / ML | SOLUTION · BLOCK/INFILTRATION | PIERREL S.P.A. |
| ORABLOC 1:200,000 | 02361906 | 0.009 MG / ML; 40 MG / ML | SOLUTION · BLOCK/INFILTRATION | PIERREL S.P.A. |
| POSICAINE N | 02381311 | 40 MG / ML; 0.005 MG / ML | SOLUTION · BLOCK/INFILTRATION | NOVOCOL PHARMACEUTICAL OF CANADA INC |
| POSICAINE SP | 02381338 | 0.01 MG / ML; 40 MG / ML | SOLUTION · BLOCK/INFILTRATION | NOVOCOL PHARMACEUTICAL OF CANADA INC |
| SEPTANEST N | 02123371 | 0.005 MG / ML; 40 MG / ML | SOLUTION · BLOCK/INFILTRATION | SEPTODONT |
| SEPTANEST SP | 02123398 | 0.01 MG / ML; 40 MG / ML | SOLUTION · BLOCK/INFILTRATION | SEPTODONT |
| ULTRACAINE D-S FORTE INJECTION | 01988557 | 0.01 MG / ML; 40 MG / ML | SOLUTION · BLOCK/INFILTRATION | HANSAMED LIMITED |
| ULTRACAINE D-S INJECTION | 01988530 | 5 MCG / ML; 40 MG / ML | SOLUTION · BLOCK/INFILTRATION | HANSAMED LIMITED |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.